On CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer shared his insights on Target, Zoetis, PROCEPT BioRobotics, and Consolidated Edison. He praised Target’s strong second-quarter performance and Zoetis’s impressive financial results. While he highlighted the growth potential of PROCEPT BioRobotics, he recommended investors consider Intuitive Surgical (ISRG) instead for robotics investments. Cramer also expressed his continued confidence in Consolidated Edison, citing its consistent performance and attractive dividend yield.
